Recombinant DNA technology is transforming healthcare, agriculture, and environmental science, notably through the development of targeted therapies. By utilizing gene editing and delivery systems, biotechnology firms can create personalized medicines, enhancing treatment efficacy. For example, a firm might design a therapy targeting specific cancer mutations by using engineered viral vectors to deliver corrective genes, minimizing side effects and improving patient quality of life.